BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 12541180)

  • 21. Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C.
    Solis-Herruzo JA; Pérez-Carreras M; Rivas E; Fernández-Vázquez I; Garfia C; Bernardos E; Castellano G; Colina F
    Am J Gastroenterol; 2005 May; 100(5):1091-8. PubMed ID: 15842583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms].
    Spahr L; Rubbia-Brandt L; Hadengue A
    Rev Med Suisse; 2005 Sep; 1(31):2026-8, 2030-1. PubMed ID: 16212004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.
    McCullough AJ
    Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonalcoholic fatty liver disease of obesity.
    Sachdev MS; Riely CA; Madan AK
    Obes Surg; 2006 Nov; 16(11):1412-9. PubMed ID: 17132404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonalcoholic steatohepatitis: what we know in the new millennium.
    Harrison SA; Kadakia S; Lang KA; Schenker S
    Am J Gastroenterol; 2002 Nov; 97(11):2714-24. PubMed ID: 12425538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Steatohepatitis and metabolic and nutritional abnormalities].
    Deugnier Y; Lainé F
    Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B9-12. PubMed ID: 12843931
    [No Abstract]   [Full Text] [Related]  

  • 27. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Non-alcoholic steato-hepatitis].
    Linhart HG
    Praxis (Bern 1994); 2000 May; 89(22):963-6. PubMed ID: 10893995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Non alcoholic steatohepatitis: an emergent and potentially serious pathology].
    Elloumi H; Arfaoui D; Joudène M; Sriha B; Korbi M; Ajmi S
    Tunis Med; 2004 Jun; 82(6):484-91. PubMed ID: 15517946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum ubiquitin levels in patients with nonalcoholic steatohepatitis.
    Savas MC; Koruk M; Pirim I; Yilmaz O; Karakok M; Taysi S; Yilmaz A
    Hepatogastroenterology; 2003; 50(51):738-41. PubMed ID: 12828075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic steatohepatitis.
    Diehl AM
    Semin Liver Dis; 1999; 19(2):221-9. PubMed ID: 10422202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Approach to the diagnosis and treatment of nonalcoholic fatty liver disease.
    Ong JP; Younossi ZM
    Clin Liver Dis; 2005 Nov; 9(4):617-34, vi. PubMed ID: 16207567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
    Miele L; Forgione A; Hernandez AP; Gabrieli ML; Vero V; Di Rocco P; Greco AV; Gasbarrini G; Gasbarrini A; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):273-7. PubMed ID: 16231589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss.
    Luyckx FH; Lefebvre PJ; Scheen AJ
    Diabetes Metab; 2000 Apr; 26(2):98-106. PubMed ID: 10804323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.
    Wanless IR; Shiota K
    Semin Liver Dis; 2004 Feb; 24(1):99-106. PubMed ID: 15085490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Steatosis and cirrhosis secondary to insulin resistance in children. Possible physiopathological mechanisms].
    Bonet Serra B; Barrio Merino A; Quintanar Rioja A; Alavés Buforn M; Nevado Santos M
    An Esp Pediatr; 2002 Apr; 56(4):353-6. PubMed ID: 11927081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition.
    Cave M; Deaciuc I; Mendez C; Song Z; Joshi-Barve S; Barve S; McClain C
    J Nutr Biochem; 2007 Mar; 18(3):184-95. PubMed ID: 17296492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic steatohepatitis.
    Brunt EM
    Semin Liver Dis; 2004 Feb; 24(1):3-20. PubMed ID: 15085483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S; Younossi ZM
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of nonalcoholic steatohepatitis (NASH).
    Ma X; Li Z
    Chin J Dig Dis; 2006; 7(1):7-11. PubMed ID: 16412031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.